Fujian Aonong Biological Technology Group Incorporation Ltd (603363) - Total Liabilities
Based on the latest financial reports, Fujian Aonong Biological Technology Group Incorporation Ltd (603363) has total liabilities worth CN¥5.36 Billion CNY (≈ $784.77 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Fujian Aonong Biological Technology Group Incorporation Ltd - Total Liabilities Trend (2013–2024)
This chart illustrates how Fujian Aonong Biological Technology Group Incorporation Ltd's total liabilities have evolved over time, based on quarterly financial data. See 603363 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Fujian Aonong Biological Technology Group Incorporation Ltd Competitors by Total Liabilities
The table below lists competitors of Fujian Aonong Biological Technology Group Incorporation Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Shelly Group SE
XETRA:SLYG
|
Germany | €25.15 Million |
|
Jihua Group Corp Ltd
SHG:601718
|
China | CN¥6.14 Billion |
|
MD Pictures Tbk PT
JK:FILM
|
Indonesia | Rp566.76 Billion |
|
Equital
TA:EQTL
|
Israel | ILA12.89 Billion |
|
Guangzhou Ruoyuchen Information Tec
SHE:003010
|
China | CN¥1.40 Billion |
|
180 Life Sciences Corp
NASDAQ:ATNF
|
USA | $564.18 Million |
|
Shenzhen Pacific Union Precision Manufacturing Co. Ltd. A
SHG:688210
|
China | CN¥1.85 Billion |
|
BioPharma Credit PLC
LSE:BPCR
|
UK | $7.49 Million |
Liability Composition Analysis (2013–2024)
This chart breaks down Fujian Aonong Biological Technology Group Incorporation Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Fujian Aonong Biological Technology Grou (603363) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.02 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.60 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.59 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Fujian Aonong Biological Technology Group Incorporation Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Fujian Aonong Biological Technology Group Incorporation Ltd (2013–2024)
The table below shows the annual total liabilities of Fujian Aonong Biological Technology Group Incorporation Ltd from 2013 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥6.44 Billion ≈ $943.10 Million |
-54.38% |
| 2023-12-31 | CN¥14.13 Billion ≈ $2.07 Billion |
-7.22% |
| 2022-12-31 | CN¥15.23 Billion ≈ $2.23 Billion |
+2.15% |
| 2021-12-31 | CN¥14.91 Billion ≈ $2.18 Billion |
+83.69% |
| 2020-12-31 | CN¥8.12 Billion ≈ $1.19 Billion |
+123.07% |
| 2019-12-31 | CN¥3.64 Billion ≈ $532.37 Million |
+58.45% |
| 2018-12-31 | CN¥2.30 Billion ≈ $335.99 Million |
+46.01% |
| 2017-12-31 | CN¥1.57 Billion ≈ $230.11 Million |
+40.66% |
| 2016-12-31 | CN¥1.12 Billion ≈ $163.59 Million |
+23.83% |
| 2015-12-31 | CN¥902.85 Million ≈ $132.11 Million |
+26.82% |
| 2014-12-31 | CN¥711.92 Million ≈ $104.18 Million |
+17.85% |
| 2013-12-31 | CN¥604.09 Million ≈ $88.40 Million |
-- |
About Fujian Aonong Biological Technology Group Incorporation Ltd
Fujian Aonong Biological Technology Group Incorporation Limited engages in the feed, pig farming, food, supply chain services, and other businesses in China and internationally. It researches and develops, produces, and sells feed products, such as pig feed, poultry feed, aquatic feed, ruminant feed, and other products; operates pig breeding farms; and engages in the pig slaughtering and processi… Read more